Peptide Cycling Protocols

Introduction

Peptide cycling involves strategic timing of use and rest periods to optimize benefits while managing potential drawbacks.

Cycling Fundamentals

Purpose of Cycling

Goal	Mechanism	Benefit
Receptor sensitivity	Prevent downregulation	Sustained response
Health monitoring	Assessment periods	Safety
Cost management	Structured use	Practical
Goal alignment	Phase-specific	Optimization

Basic Cycle Structure

Phase	Duration	Purpose
On-cycle	8-16 weeks	Active use
Off-cycle	4-8 weeks	Recovery
Bridge (optional)	Variable	Transition

Common Protocols

Growth Hormone Secretagogues

Protocol	Structure	Notes
Standard	12 weeks on, 4 weeks off	Most common
Extended	16 weeks on, 6 weeks off	Advanced users
5-on-2-off	Daily cycling	Receptor management

Recovery Peptides (BPC-157, TB-500)

Protocol	Duration	Purpose
Injury-specific	4-8 weeks	Targeted healing
Maintenance	Low dose ongoing	Prevention
Loading	2 weeks high, then reduce	Acute injury

Stacking Strategies

Synergistic Combinations

Stack	Purpose	Considerations
GHRP + GHRH analog	GH optimization	Timing critical
BPC-157 + TB-500	Recovery enhancement	Complementary mechanisms
Ipamorelin + CJC-1295	Sustained GH support	Popular combination

Timing Considerations

Factor	Recommendation	Rationale
GHRP timing	Empty stomach	Ghrelin mimetic effect
Training proximity	Pre or post	Goal-dependent
Sleep enhancement	Before bed	GH pulse amplification
Stacking intervals	15-30 min apart	Maximize response

Monitoring During Cycles

Key Markers

Marker	Frequency	Purpose
IGF-1 levels	Monthly	Efficacy assessment
Fasting glucose	Monthly	Metabolic monitoring
Liver enzymes	Quarterly	Safety
Blood pressure	Weekly	Cardiovascular

Adjustment Indicators

Side effects emerging
Plateau in response
Blood marker changes
Goal achievement

Conclusion

Effective peptide cycling requires understanding individual response, maintaining health monitoring, and adjusting protocols based on goals and markers.

Comparison table

Dimension	Peptides	SARMs	Traditional protocols
Mechanism	Pathway-specific signaling	Androgen or repair pathway	Variable by protocol
Primary use case	Targeted research question	Performance or repair comparison	Baseline comparator
Typical dose range	Compound-specific	Compound-specific	Unknown
Half-life	Varies by peptide	Varies by compound	Unknown
Common side effects	Injection reactions	Hormone or tissue risk	Protocol-dependent
WADA status	Check current list	Often prohibited	Check current list
Evidence strength	low/medium	medium	low